Greg Timblin
CEO @ Inapill || 1st-in-class therapies targeting immunometabolism to defeat age-related chronic inflammatory & autoimmune disease.
- Role
- CEO & Co-founder at Inapill
- Location
- Berkeley, CA, US
- LinkedIn followers
- 500 followers
About Greg Timblin
Greg grew up in the village of Greenwood, Nebraska (VOG, pop.531) and is a proud graduate…
Experience
CEO & Co-founder
Nov 2023 — Present · Berkeley, CA, US
Inapill is developing novel therapeutics that tune immune cell metabolism (immunometabolism) to treat disease. Co-founded by Greg Timblin, Joshua Farahzad, and the therapeutics team @ General Inception. Tenant at the Bakar BioEnginuity Hub & Bakar Labs @ UC Berkeley.
Skills
- Polymerase Chain Reaction (Pcr)
- Molecular Cloning
- Biochemistry
- Western Blotting
- Mammalian Cell Culture
- Dna
- Leukemia
- Immunology
- Assay Development
- Pcr
- Chromatin Immunoprecipitation
- Protein Purification
- Molecular Biology
- Fluorescence Microscopy
- Cell Culture
- Qpcr
- Cell Biology
- Cancer Cell Biology
- Molecular Immunology
- Flow Cytometry
- Protein Expression
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.